Pricing Log in Create free account

bioAffinity Technologies, Inc. (BIAF) vs ENDRA Life Sciences Inc. (NDRA)

bioAffinity Technologies, Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. ENDRA Life Sciences Inc. is the larger, with a market value of $7.5M against $3.3M — 2.2× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −278.9%) and the higher return on invested capital (−539.9% vs −563.2%). Across the 15 metrics below, ENDRA Life Sciences Inc. leads on 12 and bioAffinity Technologies, Inc. on 3.

Valuation

Metric BIAF NDRA Diagnostics & Research median
P/E n/m n/m 35.23
P/S 0.17 17.50 4.08
P/B 0.24 0.99 3.45
Price to free cash flow n/m n/m 33.72
EV/EBITDA 0.07 n/m 25.01
EV/Sales (0.17) 2.18 5.20
Earnings yield (3,784.57%) (125.16%) (1.47%)
Free cash flow yield (1,369.51%) (125.22%) 0.00%

Profitability

Metric BIAF NDRA Diagnostics & Research median
Gross margin 0.00% 0.00% 48.32%
Operating margin (246.14%) 0.00% (5.68%)
Net margin (278.93%) 0.00% (4.10%)
Free cash flow margin (235.89%) 0.00% 0.00%
Return on equity (240.49%) (152.04%) 0.00%
Return on assets (161.37%) (110.08%) (6.05%)
Return on invested capital (563.18%) (539.89%) 0.00%

Growth

Metric BIAF NDRA Diagnostics & Research median
Revenue growth (TTM) (18.47%) — 9.15%
EPS growth (last fiscal year) 61.55% 84.32% 20.36%
Revenue growth, 5-year CAGR — — 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIAF NDRA Diagnostics & Research median
Debt to equity 0.04 0.00 0.04
Current ratio 1.51 7.10 2.27
Net debt to EBITDA 0.57 0.14 0.68

Dividend

Metric BIAF NDRA Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric BIAF NDRA Diagnostics & Research median
Market cap 3.34m 7.51m 1.93b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack